Waters Corporation
Waters Corporation Presents Financial Outlook and Proposed Transaction at J.P. Morgan Healthcare Conference
Summary
Waters Corporation furnished an investor presentation at the J.P. Morgan 44th Annual Healthcare Conference on January 12, 2026. The presentation included high-level commentary on the Company's business performance, future financial outlook, and a proposed transaction with Augusta SpinCo Corporation and Becton, Dickinson and Company. The presentation highlighted Waters' strong financial profile, industry-leading growth, and significant value creation opportunity from the proposed transaction. Key financial metrics, such as organic constant-currency revenue growth, free cash flow, and adjusted operating margin, were provided. The proposed transaction aims to accelerate high-growth adjacencies, achieve cost and revenue synergies, and expand Waters' Total Addressable Market to $40B in attractive, growth-accretive markets.
Get alerts for WAT
Be first to know when Waters Corporation files with the SEC.
Filing Categories
Advertisement
About Waters Corporation
Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.
Official SEC Documents
Advertisement